Cargando…
Placental malaria vaccine candidate antigen VAR2CSA displays atypical domain architecture in some Plasmodium falciparum strains
Two vaccines based on Plasmodium falciparum protein VAR2CSA are currently in clinical evaluation to prevent placental malaria (PM), but a deeper understanding of var2csa variability could impact vaccine design. Here we identified atypical extended or truncated VAR2CSA extracellular structures and co...
Autores principales: | Doritchamou, Justin Y. A., Morrison, Robert, Renn, Jonathan P., Ribeiro, Jose, Duan, Junhui, Fried, Michal, Duffy, Patrick E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6897902/ https://www.ncbi.nlm.nih.gov/pubmed/31840102 http://dx.doi.org/10.1038/s42003-019-0704-z |
Ejemplares similares
-
Structural basis for placental malaria mediated by Plasmodium falciparum VAR2CSA
por: Ma, Rui, et al.
Publicado: (2021) -
A conformational epitope in placental malaria vaccine antigen VAR2CSA: What does it teach us?
por: Doritchamou, Justin Y. A., et al.
Publicado: (2023) -
A single full-length VAR2CSA ectodomain variant purifies broadly neutralizing antibodies against placental malaria isolates
por: Doritchamou, Justin YA, et al.
Publicado: (2022) -
Allelic variants of full-length VAR2CSA, the placental malaria vaccine candidate, differ in antigenicity and receptor binding affinity
por: Renn, Jonathan P., et al.
Publicado: (2021) -
Author Correction: Allelic variants of full-length VAR2CSA, the placental malaria vaccine candidate, differ in antigenicity and receptor binding affinity
por: Renn, Jonathan P., et al.
Publicado: (2022)